Guilhot, Francois http://orcid.org/0000-0001-7222-487X
Rigal-Huguet, Françoise
Guilhot, Joëlle
Guerci-Bresler, Agnès-Paule
Maloisel, Frédéric
Rea, Delphine
Coiteux, Valérie
Gardembas, Martine
Berthou, Christian
Vekhoff, Anne
Jourdan, Eric
Berger, Marc
Fouillard, Loïc
Alexis, Magda
Legros, Laurence
Rousselot, Philippe
Delmer, Alain http://orcid.org/0000-0002-1430-2574
Lenain, Pascal
Escoffre Barbe, Martine
Gyan, Emmanuel http://orcid.org/0000-0002-7651-9189
Bulabois, Claude-Eric
Dubruille, Viviane
Joly, Bertrand http://orcid.org/0000-0002-4136-9002
Pollet, Bertrand
Cony-Makhoul, Pascale
Johnson-Ansah, Hyacinthe
Mercier, Melanie
Caillot, Denis
Charbonnier, Aude
Kiladjian, Jean-Jacques
Chapiro, Jacques
Penot, Amélie
Dorvaux, Véronique
Vaida, Iona
Santagostino, Alberto
Roy, Lydia
Zerazhi, Hacene
Deconinck, Eric http://orcid.org/0000-0002-6006-8088
Maisonneuve, Herve
Plantier, Isabelle
Lebon, Delphine
Arkam, Yazid
Cambier, Nathalie
Ghomari, Kamel
Miclea, Jean-Michel
Glaisner, Sylvie
Cayuela, Jean-Michel
Chomel, Jean-Claude http://orcid.org/0000-0001-9227-1104
Muller, Marc
Lhermitte, Ludovic http://orcid.org/0000-0003-2498-0376
Delord, Marc http://orcid.org/0000-0002-0455-6749
Preudhomme, Claude
Etienne, Gabriel
Mahon, François-Xavier
Nicolini, Franck- Emmanuel
Guilhot, Francois
Rigal-Huguet, Francoise
Guilhot, Joëlle
Guerci-Bresler, Agnès-Paule
Rea, Delphine
Coiteux, Valérie
Gardembas, Martine
Vekhoff, Anne
Berger, Marc
Legros, Laurence
Rousselot, Philippe
Lenain, Pascal
Escoffre Barbe, Martine
Dubruille, Viviane
Cony-Makhoul, Pascale
Johnson-Ansah, Hyacinthe
Mercier, Melanie
Aude, Charbonnier
Roy, Lydia
Cambier, Nathalie
Cayuela, Jean-Michel
Chomel, Jean-Claude
Delord, Marc
Preudhomme, Claude
Etienne, Gabriel
Mahon, François-Xavier
Nicolini, Franck-Emmanuel
,
Article History
Received: 24 January 2020
Revised: 20 November 2020
Accepted: 15 December 2020
First Online: 22 January 2021
Compliance with ethical standards
:
: FG received research support from Novartis and Roche, honoraria from Novartis, BMS and Celgene; DR received honoraria from Incyte, Novartis and Pfizer; EJ received an honorarium from Novartis; LL received honoraria from Incyte, Novartis, Janssen and Pfizer; PR received research support from Pfizer and Incyte; AD received honoraria from Janssen, Abvie, Gilead, Roche, and Amgen; PCM received research support from Novartis, Pfizer, and Incyte and honoraria from Novartis and Incyte; GE received an honorarium from Novartis; FXM received honoraria from Novartis and BMS; and FEN received honoraria from Sun Pharma and Novartis and research support from Incyte.